CRIS - Consortium for Clinical Research & Innovation Singapore
WELCOME TO
CRIS - Consortium for Clinical Research & Innovation Singapore

The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly-owned subsidiary of MOH Holdings, was established in 2020 with the goal of strengthening synergies and developing strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry of Health (MOH).

Learn More
CRIS - Consortium for Clinical Research & Innovation Singapore

Our Business Units

CRIS - Consortium for Clinical Research & Innovation Singapore
CRIS - Consortium for Clinical Research & Innovation Singapore

Singapore Clinical Research Institute (SCRI)

The Singapore Clinical Research Institute (SCRI) is the national academic research organisation dedicated to enhancing the standards of clinical research and coordinating clinical trials.

LEARN MORE
CRIS - Consortium for Clinical Research & Innovation Singapore
CRIS - Consortium for Clinical Research & Innovation Singapore

National Health Innovation Centre Singapore (NHIC)

The National Health Innovation Centre Singapore (NHIC) aims to provide the publicly-funded clinical research sector of Singapore with translational funding and strategic guidance.

LEARN MORE
CRIS - Consortium for Clinical Research & Innovation Singapore
CRIS - Consortium for Clinical Research & Innovation Singapore

Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)

The Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) was established on 20 April 2020 to meet the increasing clinical demand of using cellular therapeutics to treat various life-threatening diseases.

LEARN MORE
CRIS - Consortium for Clinical Research & Innovation Singapore

Coming Soon.

For more information, please email Precision Health Research, Singapore (PRECISE) at PMCO@moh.gov.sg.

CRIS - Consortium for Clinical Research & Innovation Singapore
CRIS - Consortium for Clinical Research & Innovation Singapore

Singapore Translational Cancer Consortium (STCC)

The Singapore Translational Cancer Consortium (STCC) is a nationally-coordinated consortium to synergise cancer research capabilities in Singapore.

LEARN MORE
Top